Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Biocon Ltd

NSE: BIOCON · BSE: 532523 · Pharmaceuticals & Biotechnology · 57 announcements

Biocon Ltd news stories on ALFA NewsRead the news →
Share price
₹360.70
Market cap
₹58,783 Cr
Revenue (annual)
₹16,927 Cr
Net profit (annual)
₹385.6 Cr
P/E (TTM)
118.7×Sector 47.4×
Promoter holding
44.68%-0.23% QoQ
FII holding
8.14%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Regulatory Approval 6Earnings Call 6Annual General Meeting 6Other Announcement 4Capital Structure Change 4Business Update 4New Order Win 3Management Change 3Fund Raise 3Financial Results 3Results Update 2Product Launch 2Merger & Restructuring 2Board Meeting Outcome 2Board Meeting Date 2Acquisition 2Price Movement Clarification 1Dividend 1Annual Report 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

3 announcements with these filters

08:31 IST NSE
New Order Win

Biocon Bags New Order from Bahiafarma and Bionovis

Biocon secured a 10-year supply contract for Pertuzumab in Brazil under a government program. The partnership involves milestone payments and revenue sharing for the company.

From
Bahiafarma and Bionovis (Brazil PDP program)
Execution
10 years
Read the filing ↗
08:34 IST BSE
New Order Win

Biocon Announces New Order Win

Biocon’s subsidiary will supply insulin to Duopharma Biotech under Malaysian MoH contracts worth over MYR 225 million. The three‑year and two‑year deals expand Biocon’s presence in Malaysia’s diabetes market.

Read the filing ↗
08:33 IST NSE
New Order Win

Biocon Announces New Order Win

Biocon will supply insulin to Duopharma under contracts worth over MYR 225 million. The partnership strengthens its diabetes care footprint in Malaysia.

Read the filing ↗